Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 53

1.

Corporate social responsibility in countries with mature and emerging pharmaceutical sectors.

Volodina A, Sax S, Anderson S.

Pharm Pract (Granada). 2009 Oct;7(4):228-37. Epub 2009 Mar 15.

2.

Strategies and practices in off-label marketing of pharmaceuticals: a retrospective analysis of whistleblower complaints.

Kesselheim AS, Mello MM, Studdert DM.

PLoS Med. 2011 Apr;8(4):e1000431. doi: 10.1371/journal.pmed.1000431. Epub 2011 Apr 5.

3.

Funding for medical education: maintaining a healthy separation from industry.

Avorn J, Choudhry NK.

Circulation. 2010 May 25;121(20):2228-34. doi: 10.1161/CIRCULATIONAHA.109.869636. No abstract available.

4.

The impact of disclosing financial ties in research and clinical care: a systematic review.

Licurse A, Barber E, Joffe S, Gross C.

Arch Intern Med. 2010 Apr 26;170(8):675-82. doi: 10.1001/archinternmed.2010.39. Review.

PMID:
20421551
5.

Norwegian medical students' attitudes towards the pharmaceutical industry.

Lea D, Spigset O, Slørdal L.

Eur J Clin Pharmacol. 2010 Jul;66(7):727-33. doi: 10.1007/s00228-010-0805-6. Epub 2010 Mar 19.

PMID:
20300742
6.

Do medical students copy the drug treatment choices of their teachers or do they think for themselves?

Tichelaar J, Richir MC, Avis HJ, Scholten HJ, Antonini NF, De Vries TP.

Eur J Clin Pharmacol. 2010 Apr;66(4):407-12. doi: 10.1007/s00228-009-0743-3. Epub 2009 Nov 24.

7.

The devil is in the third year: a longitudinal study of erosion of empathy in medical school.

Hojat M, Vergare MJ, Maxwell K, Brainard G, Herrine SK, Isenberg GA, Veloski J, Gonnella JS.

Acad Med. 2009 Sep;84(9):1182-91. doi: 10.1097/ACM.0b013e3181b17e55. Erratum in: Acad Med. 2009 Nov;84(11):1616.

PMID:
19707055
8.

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.

Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D.

Ann Intern Med. 2009 Aug 18;151(4):W65-94. Epub 2009 Jul 20.

PMID:
19622512
9.

Effect of exposure to small pharmaceutical promotional items on treatment preferences.

Grande D, Frosch DL, Perkins AW, Kahn BE.

Arch Intern Med. 2009 May 11;169(9):887-93. doi: 10.1001/archinternmed.2009.64.

PMID:
19433701
10.

A longitudinal comparison of pharmacy and medical students' attitudes toward the medically underserved.

Crandall SJ, Davis SW, Broeseker AE, Hildebrandt C.

Am J Pharm Educ. 2008 Dec 15;72(6):148.

11.

Exposure of medical students to pharmaceutical marketing in primary care settings: frequent and influential.

Sarikaya O, Civaner M, Vatansever K.

Adv Health Sci Educ Theory Pract. 2009 Dec;14(5):713-24. doi: 10.1007/s10459-009-9153-7. Epub 2009 Jan 30.

PMID:
19184498
12.

The Neurontin legacy--marketing through misinformation and manipulation.

Landefeld CS, Steinman MA.

N Engl J Med. 2009 Jan 8;360(2):103-6. doi: 10.1056/NEJMp0808659. No abstract available.

PMID:
19129523
13.

Effect of legislative changes in drug promotion on medical students: questionnaire survey.

Vuorenkoski L, Valta M, Helve O.

Med Educ. 2008 Dec;42(12):1172-7. doi: 10.1111/j.1365-2923.2008.03169.x.

PMID:
19120947
14.

Perceived advantages and disadvantages of using drug samples in a university hospital center: a case study.

Tardif L, Bailey B, Bussières JF, Lebel D, Soucy G.

Ann Pharmacother. 2009 Jan;43(1):57-63. doi: 10.1345/aph.1L154. Epub 2008 Dec 23.

PMID:
19109212
15.

[Quality of pharma rep meetings in general practice].

Straand J, Christensen IJ.

Tidsskr Nor Laegeforen. 2008 Feb 28;128(5):555-7. Norwegian.

16.

Has the hunt for conflicts of interest gone too far? Yes.

Stossel TP.

BMJ. 2008 Mar 1;336(7642):476. doi: 10.1136/bmj.39493.489213.AD. No abstract available.

17.

The hidden curriculum: medical students' changing opinions toward the pharmaceutical industry.

Fitz MM, Homan D, Reddy S, Griffith CH 3rd, Baker E, Simpson KP.

Acad Med. 2007 Oct;82(10 Suppl):S1-3.

PMID:
17895670
18.
19.

Attitudes of preclinical and clinical medical students toward interactions with the pharmaceutical industry.

Hyman PL, Hochman ME, Shaw JG, Steinman MA.

Acad Med. 2007 Jan;82(1):94-9.

PMID:
17198299
20.

Health industry practices that create conflicts of interest: a policy proposal for academic medical centers.

Brennan TA, Rothman DJ, Blank L, Blumenthal D, Chimonas SC, Cohen JJ, Goldman J, Kassirer JP, Kimball H, Naughton J, Smelser N.

JAMA. 2006 Jan 25;295(4):429-33.

PMID:
16434633

Supplemental Content

Support Center